Bedtime doses of prazosin do not affect daytime salivary amylase markers in PTSD

William Vaughn McCall, Anilkumar R Pillai, Chirayukumar D Pandya, Laryssa McCloud, Jason A. Moraczewski, Liniya Tauhidul, Nagy Adel Youssef, Doug Case, Peter B. Rosenquist

Research output: Contribution to journalArticle

Abstract

Overactivity of the noradrenergic (NE) system within the central nervous system (CNS) has been postulated as a key pathophysiology of posttraumatic stress disorder (PTSD). The activity of the enzyme salivary α-amylase (sAA) has been proposed as an indirect measure of CNS NE activity, and sAA is elevated in PTSD. As an antagonist of the α-1 NE receptor, prazosin would be expected to alter sAA values in PTSD patients. However, given its short half-life, it is not clear whether bedtime doses would have an effect on daytime sAA. In the present study, we assayed daytime sAA in 20 suicidal PTSD patients who were randomized to prazosin versus placebo at bedtime-only, and found no effect in daytime sAA. These findings are consistent with studies showing an advantage for twice daily dosing of prazosin in PTSD.

Original languageEnglish (US)
Article numbere01709
JournalHeliyon
Volume5
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Prazosin
Amylases
Post-Traumatic Stress Disorders
Central Nervous System
Half-Life
Placebos
Enzymes

Keywords

  • Psychiatry

ASJC Scopus subject areas

  • General

Cite this

Bedtime doses of prazosin do not affect daytime salivary amylase markers in PTSD. / McCall, William Vaughn; Pillai, Anilkumar R; Pandya, Chirayukumar D; McCloud, Laryssa; Moraczewski, Jason A.; Tauhidul, Liniya; Youssef, Nagy Adel; Case, Doug; Rosenquist, Peter B.

In: Heliyon, Vol. 5, No. 5, e01709, 01.05.2019.

Research output: Contribution to journalArticle

McCall, William Vaughn ; Pillai, Anilkumar R ; Pandya, Chirayukumar D ; McCloud, Laryssa ; Moraczewski, Jason A. ; Tauhidul, Liniya ; Youssef, Nagy Adel ; Case, Doug ; Rosenquist, Peter B. / Bedtime doses of prazosin do not affect daytime salivary amylase markers in PTSD. In: Heliyon. 2019 ; Vol. 5, No. 5.
@article{1e45e0fe99374f5c801681ab8ee98924,
title = "Bedtime doses of prazosin do not affect daytime salivary amylase markers in PTSD",
abstract = "Overactivity of the noradrenergic (NE) system within the central nervous system (CNS) has been postulated as a key pathophysiology of posttraumatic stress disorder (PTSD). The activity of the enzyme salivary α-amylase (sAA) has been proposed as an indirect measure of CNS NE activity, and sAA is elevated in PTSD. As an antagonist of the α-1 NE receptor, prazosin would be expected to alter sAA values in PTSD patients. However, given its short half-life, it is not clear whether bedtime doses would have an effect on daytime sAA. In the present study, we assayed daytime sAA in 20 suicidal PTSD patients who were randomized to prazosin versus placebo at bedtime-only, and found no effect in daytime sAA. These findings are consistent with studies showing an advantage for twice daily dosing of prazosin in PTSD.",
keywords = "Psychiatry",
author = "McCall, {William Vaughn} and Pillai, {Anilkumar R} and Pandya, {Chirayukumar D} and Laryssa McCloud and Moraczewski, {Jason A.} and Liniya Tauhidul and Youssef, {Nagy Adel} and Doug Case and Rosenquist, {Peter B.}",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.heliyon.2019.e01709",
language = "English (US)",
volume = "5",
journal = "Heliyon",
issn = "2405-8440",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Bedtime doses of prazosin do not affect daytime salivary amylase markers in PTSD

AU - McCall, William Vaughn

AU - Pillai, Anilkumar R

AU - Pandya, Chirayukumar D

AU - McCloud, Laryssa

AU - Moraczewski, Jason A.

AU - Tauhidul, Liniya

AU - Youssef, Nagy Adel

AU - Case, Doug

AU - Rosenquist, Peter B.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Overactivity of the noradrenergic (NE) system within the central nervous system (CNS) has been postulated as a key pathophysiology of posttraumatic stress disorder (PTSD). The activity of the enzyme salivary α-amylase (sAA) has been proposed as an indirect measure of CNS NE activity, and sAA is elevated in PTSD. As an antagonist of the α-1 NE receptor, prazosin would be expected to alter sAA values in PTSD patients. However, given its short half-life, it is not clear whether bedtime doses would have an effect on daytime sAA. In the present study, we assayed daytime sAA in 20 suicidal PTSD patients who were randomized to prazosin versus placebo at bedtime-only, and found no effect in daytime sAA. These findings are consistent with studies showing an advantage for twice daily dosing of prazosin in PTSD.

AB - Overactivity of the noradrenergic (NE) system within the central nervous system (CNS) has been postulated as a key pathophysiology of posttraumatic stress disorder (PTSD). The activity of the enzyme salivary α-amylase (sAA) has been proposed as an indirect measure of CNS NE activity, and sAA is elevated in PTSD. As an antagonist of the α-1 NE receptor, prazosin would be expected to alter sAA values in PTSD patients. However, given its short half-life, it is not clear whether bedtime doses would have an effect on daytime sAA. In the present study, we assayed daytime sAA in 20 suicidal PTSD patients who were randomized to prazosin versus placebo at bedtime-only, and found no effect in daytime sAA. These findings are consistent with studies showing an advantage for twice daily dosing of prazosin in PTSD.

KW - Psychiatry

UR - http://www.scopus.com/inward/record.url?scp=85065441544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065441544&partnerID=8YFLogxK

U2 - 10.1016/j.heliyon.2019.e01709

DO - 10.1016/j.heliyon.2019.e01709

M3 - Article

AN - SCOPUS:85065441544

VL - 5

JO - Heliyon

JF - Heliyon

SN - 2405-8440

IS - 5

M1 - e01709

ER -